Vascular growth factors in neuropsychiatry

Cell Mol Life Sci. 2013 May;70(10):1739-52. doi: 10.1007/s00018-013-1281-9. Epub 2013 Mar 12.

Abstract

Recent advances in understanding the cellular and molecular basis of psychiatric illnesses have shed light on the important role played by trophic factors in modulating functional parameters associated with disease causality and drug action. Disease mechanisms are now thought to involve multiple cell types, including neurons and endothelial cells. These functionally distinct but interactively coupled cell types engage in cellular cross talk via shared and common signaling molecules. Dysregulation in their cellular signaling pathways influences brain function and alters behavioral performance. Multifunctional trophic factors such as VEGF and EPO that possess both neurotrophic and angiogenic actions are of particular interest due to their ability to rescue structural and plasticity deficits in neurons and vasculature. Obtaining insight into the behavioral, cellular and molecular actions of multi-functional trophic factors has the potential to open new and transformative therapeutic approaches.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antidepressive Agents / therapeutic use
  • Astrocytes / metabolism
  • Behavior, Animal / drug effects
  • Biomimetics
  • Cognition Disorders / metabolism*
  • Cognition Disorders / pathology
  • Depression / drug therapy
  • Depression / metabolism*
  • Depression / pathology
  • Disease Models, Animal
  • Endothelial Cells / metabolism
  • Erythropoietin / metabolism
  • Erythropoietin / pharmacology
  • Erythropoietin / therapeutic use
  • Humans
  • Neurons / cytology
  • Neurons / metabolism
  • Vascular Endothelial Growth Factors / genetics
  • Vascular Endothelial Growth Factors / metabolism*

Substances

  • Antidepressive Agents
  • Vascular Endothelial Growth Factors
  • Erythropoietin